The local immune response in the airways and blood of contacts early after TB exposure determines outcome
In plain English
AI plain-English summaryA simple blood test can reveal whether someone recently exposed to tuberculosis (TB) will go on to develop active disease or remain healthy. Most people infected with *Mycobacterium tuberculosis* never get sick, but doctors cannot predict who will progress to active TB. The critical immune events in the lungs and airways right after exposure remain a black box. This research aims to open that box by tracking immune changes in the airways and blood of recent TB contacts, comparing them with active TB patients in a low-TB-burden setting like the UK. If successful, this work could transform TB control. A reliable early-warning signature would allow clinicians to target preventive treatment only to those who truly need it, sparing the majority from unnecessary drugs. It would also reveal which immune responses protect against progression—information essential for designing better vaccines. Currently, the only TB vaccine, BCG, has variable efficacy. Understanding the local early immune response could guide the development of vaccines that trigger the right defences from the start, potentially cutting transmission chains before disease ever appears.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know